News releases

Back to the news list
September 5, 2012

Aeterna Zentaris to Present at Rodman & Renshaw 14th Annual Global Investment Conference in New York

Québec City, Canada, September 5, 2012 - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its President and CEO, Juergen Engel, PhD, will be presenting a corporate overview at the Rodman & Renshaw 14th Annual Global Investment Conference on Tuesday, September 11, 2012, at 1:35 pm (Eastern), in the Starlight North Room of The WaldorfAstoria Hotel in New York.

A live webcast of this presentation will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com.

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com

Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com

-30-